Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: A practical application

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 375, Issue 2, 2007, Pages 105-114

  Luszczki, Jarogniew J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Chimney test; Dose response relationship curve; Gabapentin; Isobolographic analysis; Maximal electroshock seizure test; Pharmacodynamic interaction; Topiramate

Indexed keywords

GABAPENTIN; TOPIRAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CHIMNEY; CONTROLLED STUDY; COORDINATION DISORDER; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG POTENTIATION; ELECTRIC SHOCK; EPILEPSY; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN;

AMINES; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROSHOCK; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MODELS, BIOLOGICAL; MOTOR SKILLS DISORDERS; NEUROPROTECTIVE AGENTS; REGRESSION ANALYSIS; SEIZURES; TIME FACTORS;

EID: 33947193434     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0144-z     Document Type: Article

References (35)

1. Bartoszyk GD, Meyerson M, Reimann W, Satzinger G, von Hodenberg A (1986) Gabapentin. In: Meldrum BS, Porter RJ (eds) New anticonvulsant drugs. Libbey, London, pp 147-163
2. Berenbaum MC (1989) What is synergy? Pharmacol Rev 41:93-141 (erratum published in 1989, Pharmacol Rev 41:422)
3. Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l'action tranquilisante le test de la cheminee. Med Exp 3:81-84 (Basel)
4. Borowicz KK, Swiader M, Luszczki J, Czuczwar SJ (2002) Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice - an isobolographic analysis. Epilepsia 43:956-963
5. Dalby NO, Nielsen EB (1997) Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 28:63-72
6. Deckers CLP, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos P, Renier WO, van Rijn CM (2000) Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed. Epilepsia 41:1364-1374
7. Grabovsky Y, Tallarida RJ (2004) Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310:981-986
8. Greco WR, Bravo G, Parsons JC (1995) The search for synergy: a critical review from response surface perspective. Pharmacol Rev 47:331-385
9. Leach JP (2000) Antiepileptic drugs: safety in numbers? Seizure 9:170-178
10. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
11. Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290
12. Luszczki JJ, Czuczwar SJ (2003) Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics - a comparative study. Epilepsy Res 56:27-42
13. Luszczki JJ, Czuczwar SJ (2004a) Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia 45:895-907
14. Luszczki JJ, Czuczwar SJ (2004b) Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn-Schmiedeberg's Arch Pharmacol 369:434-446
15. Luszczki JJ, Czuczwar SJ (2006) Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis. Naunyn- Schmiedeberg's Arch Pharmacol 374:51-64
16. Luszczki JJ, Swiader M, Parada-Turska J, Czuczwar SJ (2003a) Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology 28:1817-1830
17. Luszczki JJ, Borowicz KK, Swiader M, Czuczwar SJ (2003b) Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44:489-499
18. Luszczki JJ, Czuczwar M, Kis J, Krysa J, Pasztelan I, Swiader M, Czuczwar SJ (2003c) Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44:1003-1013
19. Luszczki JJ, Andres MM, Czuczwar SJ (2005a) Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model - an isobolographic analysis. Eur J Pharmacol 515:54-61
20. Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ (2005b) Pharmacodynamic and pharmacokinetic interaction studies with loreclezole and felbamate, lamotrigine, topiramate and oxcarbazepine in the mouse maximal electroshock seizure model. Epilepsia 46:344-355
21. Luszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Ratnaraj N, Patsalos PN, Czuczwar SJ (2006a) Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Epilepsia 47:10-20
22. Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ (2006b) Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electro-shock-induced seizure model. Naunyn-Schmiedeberg's Arch Pharmacol 373:169-181
23. Löscher W, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Res 9:1-10
24. Löscher W, Wauquier A (1996) Use of animal models in developing guiding principles for polypharmacy in epilepsy. Epilepsy Res Suppl 11:61-65
25. Löscher W, Fassbender CP, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8:79-94
26. Perucca E (1995) Pharmacological principles as a basis for poly-therapy. Acta Neurol Scand Suppl 162:31-34
27. Porreca F, Jiang Q, Tallarida RJ (1990) Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. Eur J Pharmacol 179:463-468
28. Schmidt D (1996) Modern management of epilepsy: Rational polytherapy. Bailliere's Clin Neurol 5:757-763
29. Shank RP, Gardocki JF, Vaught JL, Davis CB, Schupsky JJ, Raffa RB, Dodgson SJ, Nortey SO, Maryanoff BE (1994) Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia 35:450-460
30. Sills GJ, Butler E, Thompson GG, Brodie MJ (2004) Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models. Seizure 13:287-295
31. Stephen LJ, Brodie MJ (2002) Seizure-freedom on more than one antiepileptic drug. Seizure 11:349-351
32. Tallarida RJ (2000) Drug synergism and dose-effect data analysis. CRC, Boca Raton, FL
33. Tallarida RJ (2006) An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319:1-7
34. Tallarida RJ (2007) Interactions between drugs and occupied receptors. Pharmacol Ther 113:197-209
35. White HS, Woodhead JH, Wilcox KS, Stables JP, Kupferberg HJ, Wolf HH (2002) Discovery and preclinical development of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Williams & Wilkins, Philadelphia, pp 36-48